Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near Los Angeles, CA

132 studies for Prostate Cancer are recruiting at 271 sites within 50 miles of Los Angeles, California, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near Los Angeles.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near Los Angeles

Showing the 50 nearest of 132 studies.
  1. Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

    NCT06592924

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Cedars-Sinai Medical Center (Los Angeles, CA); Kaiser Permanente Los Angeles Medical Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    30 sites within 50 mi
  2. This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

    NCT07028853

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Cedars-Sinai Cancer at Cedars-Sinai Medical Center (Los Angeles, CA); Ronald Reagan UCLA Medical Center - Drug Information Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    19 sites within 50 mi
  3. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    NCT04423211

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: UCLA / Jonsson Comprehensive Cancer Center (Los Angeles, CA); City of Hope South Pasadena (South Pasadena, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  4. A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

    NCT06629779

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Los Angeles Cancer Network (LACN) (Los Angeles, CA); Los Angeles Cancer Network (LACN) (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  5. A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT07225946

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Ronald Reagan UCLA Medical Center (Los Angeles, CA); USC Norris Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  6. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    NCT06925737

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Cedars-Sinai Medical Center ( Site 0068) (Los Angeles, CA); UCLA Hematology/Oncology - Santa Monica ( Site 0002) (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  7. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Cedars-Sinai Medical Center (Los Angeles, CA); Tower Cancer Research Foundation (Beverly Hills, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  8. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    NCT03678025

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Los Angeles County-USC Medical Center (Los Angeles, CA); USC / Norris Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  9. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    NCT03866382

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Keck Medicine of USC Koreatown (Los Angeles, CA); Los Angeles General Medical Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  10. A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

    NCT05914116

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site 103 (Los Angeles, CA); Research Site 125 (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  11. A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

    NCT06136650

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UCLA Hematology/Oncology - Santa Monica ( Site 0044) (Los Angeles, CA); University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040) (Orange, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  12. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    NCT07200830

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Cedars-Sinai Medical Center (Los Angeles, CA); UC Irvine Health/Chao Family Comprehensive Cancer Center (Orange, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  13. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    NCT05519449

    • Phase 1
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: UCLA Department of Medicine (Los Angeles, CA); USC Norris Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  14. Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

    NCT06056830

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Greater Los Angeles VA Medical Center (Los Angeles, CA); Urology Group of Southern California (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  15. Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

    NCT06582017

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Cedars-Sanai Medical Center (Los Angeles, CA); Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  16. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    NCT07080242

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Valkyrie Clinical Trials (Los Angeles, CA); Los Alamitos Hematology/Oncology Medical Group (Glendale, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  17. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest sites: UCLA Jonsson Comprehensive Cancer Center (Los Angeles, CA); USC Norris Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    NCT04606446

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Cedars Sinai Medical Center (Los Angeles, CA); Cedars-Sinai Cancer at Cedars-Sinai Medical Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

    NCT04986423

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: California Research Institute (Los Angeles, CA); Innovative Clinical Research Institute (Whittier, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  20. Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc

    NCT05534646

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Cedars-Sinai Medical Center (Los Angeles, CA); City of Hope (Duarte, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  21. A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

    NCT05652686

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: USC Norris Comprehensive Cancer Center (Los Angeles, CA); City of Hope (City of Hope National Medical Center, City of Hope Medical Center) (Duarte, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  22. Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

    NCT05691465

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Los Angeles General Medical Center (Los Angeles, CA); USC / Norris Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  23. Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

    NCT05832086

    • Phase 2
    • Ages Any age
    • Sex: Male

    Nearest sites: Cedars-Sinai Medical Center (Los Angeles, CA); Beckman Research Institute of the City of Hope (Duarte, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  24. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    NCT05919264

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of California, Los Angeles (UCLA) (Los Angeles, CA); Sarcoma Oncology Center (Santa Monica, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  25. Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

    NCT06067295

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Los Angeles General Medical Center (Los Angeles, CA); USC / Norris Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  26. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    NCT06465069

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UCLA Department of Medicine-Hematology/Oncology (Los Angeles, CA); City of Hope National Medical Center (Duarte, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  27. Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors

    NCT06500169

    • Interventional
    • Ages 55 to 85 years
    • Sex: Male

    Nearest sites: Los Angeles General Medical Center (Los Angeles, CA); USC / Norris Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  28. Role of Race in Nutritional Approach in Men on ADT

    NCT06682390

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Greater Los Angeles Division of Veterans Affairs (Los Angeles, CA); UCLA Health 200 Medical Plaza (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  29. Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

    NCT06780670

    • Phase 2/3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: VA Greater LA Healthcare System (Los Angeles, CA); Saint Johns Cancer Institute (Santa Monica, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  30. A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    NCT06842498

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: UCLA Clark Urology Center (Los Angeles, CA); VA Greater Los Angeles Healthcare System (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  31. A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

    NCT06863272

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UCLA Hematology & Oncology ( Site 0003) (Los Angeles, CA); University of California-Irvine Medical Center ( Site 0016) (Orange, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  32. A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT07164443

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Cedars Sinai Medical Center (Los Angeles, CA); Ronald Reagan UCLA Medical Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  33. Active Surveillance for Cancer of the Prostate (ASCaP)

    NCT00949819

    • Observational
    • Ages 30 to 85 years
    • Sex: Male

    Nearest site: University of California Los Angeles (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. HIFU for Focal Ablation of Prostate Tissue: An Observational Study

    NCT03620786

    • Observational
    • Ages 40 to 85 years
    • Sex: Male

    Nearest site: University of California, Los Angeles (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

    NCT04503265

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification

    NCT04765150

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: UCLA / Jonsson Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

    NCT04857502

    • Early Phase 1
    • Ages Any age
    • Sex: Male

    Nearest site: UCLA / Jonsson Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma

    NCT04945642

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California at Los Angeles / Jonsson Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

    NCT04969315

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: USC Norris Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. A Study of NX-1607 in Adults With Advanced Malignancies

    NCT05107674

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Southern California (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy

    NCT05398302

    • Phase 1
    • Ages Any age
    • Sex: Male

    Nearest site: UCLA / Jonsson Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

    NCT05417594

    • Phase 1/2
    • Ages 18 to 130 years
    • Sex: All

    Nearest site: Research Site (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

    NCT05422911

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: VA Greater Los Angeles Healthcare System (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. Mechanisms of Resistance to PSMA Radioligand Therapy

    NCT05435495

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California, Los Angeles (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

    NCT05489211

    • Phase 2
    • Ages 18 to 130 years
    • Sex: All

    Nearest site: Research Site (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making

    NCT05923684

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Cedars-Sinai Medical Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

    NCT05939414

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: VA Greater LA Healthcare System (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial

    NCT06022822

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Cedars-Sinai Medical Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial

    NCT06067269

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: UCLA / Jonsson Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

    NCT06216249

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: UCLA / Jonsson Comprehensive Cancer Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.